DEF 14A of Seritage Growth Properties
Filed Apr 27, 20260001174947-26-000519
Talya Nevo-Hacohen
Talya Nevo-Hacohen Talya Nevo-Hacohen, 66, served as EVP, Chief Investment Officer and Treasurer of Sabra Health Care REIT, Inc. from 2010 to December 2025. From September 2006 to August 2008 and from February 2009 to November 2010, Ms. Nevo-Hacohen served as an advisor to private real estate developers and operators regarding property acquisitions and dispositions, corporate capitalization, and equity and debt capital raising. Previously, Ms. Nevo-Hacohen was a Managing Director with Cerberus Real Estate Capital Management, LLC. From 2003 to 2006, Ms. Nevo-Hacohen served as Senior Vice President-Capital Markets and Treasurer for Healthpeak Properties, Inc. (“Healthpeak”) (formerly HCP, Inc.), a healthcare REIT. Prior to her time with Healthpeak, Ms. Nevo-Hacohen spent 10 years with Goldman, Sachs & Co. (“Goldman Sachs”) where she was a Vice President in the investment banking and finance, operations and administration divisions. Prior to her affiliation with Goldman Sachs, she practiced architecture and was associated with several architectural firms in New York. Ms. Nevo-Hacohen is the President of the Board of Trustees of South Coast Repertory, and also serves on the Board of Advisors of Yale University’s Jackson School of Global Affairs. Ms. Nevo-Hacohen serves as Chairman of the Board of U.S. Friends of Dror Israel, is a member of the Advisory Board of Znest, and also serves as a member of the Board of Spike’s K9 Fund. Ms. Nevo-Hacohen's experience advising REITs and finance well qualifies her to serve as a trustee of the Company.
Mark Wilsmann
| Year | Summary Compensation Table Total for Adam Metz ($) | Summary Compensation Table Total for Andrea L. Olshan ($) | Compensation Actually Paid to Adam Metz ($) | Compensation Actually Paid to Andrea L. Olshan ($) | Average Summary Compensation Table Total for Non-PEO NEOs ($) | Average Compensation Actually Paid to Non-PEO NEOs ($) | Value of Initial Fixed $100 Investment Based On Total Shareholder Return ($) | Net Income (Loss) ($ in thousands) | | (a) | (b)(1) | (c)(2) | (d)(3) | (e)(4) | (f)(5) | (g)(6) | (h)(7) | (i)(8) | | 2025 | 822,581 | 6,386,016 | 822,581 | 6,355,955 | 1,951,814 | 1,945,620 | 27 | (68,215) | | 2024 | - | 5,179,744 | - | 4,841,189 | 1,766,033 | 1,670,608 | 35 | (153,536) | | 2023 | - | 2,404,615 | - | 760,735 | 1,005,675 | 873,197 | 79 | (154,911) |
Mark Wilsmann
| (3) The dollar amount reported in column (d) represent the amount of “compensation actually paid” to Mr. Metz in 2025, as computed in accordance with Item 402(v) of Regulation S-K. Because Mr. Metz was compensated only in the form of base salary (while serving as our PEO) and director fees (while serving as our Chairman), Mr. Metz’s CAP in 2025 is the same as the total compensation reported in the Summary Compensation Table and no adjustments were required. |
Mark Wilsmann
| (4) The dollar amounts reported in column (e) represent the amount of “compensation actually paid” to Ms. Olshan for the corresponding year, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual amount of compensation earned by or paid to Ms. Olshan during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to Ms. Olshan’s total compensation to determine her 2025 CAP: |
Mark Wilsmann
| (6) The dollar amounts reported in column (g) represent the average amount of “compensation actually paid” to the Non-PEO NEOs specified in footnote 5, as computed in accordance with Item 402(v) of Regulation S-K. The dollar amounts do not reflect the actual average amount of compensation earned by or paid to the Non-PEO NEOs during the applicable year. In accordance with the requirements of Item 402(v) of Regulation S-K, the following adjustments were made to average total compensation for the Non-PEO NEOs for 2025 to determine the compensation actually paid, using the same methodology described above in footnote 4: |
Mark Wilsmann
| Name(1) | Fees Earned or Paid in Cash ($) | Total ($) | | John T. McClain | 180,000 | 180,000 | | Talya Nevo-Hacohen | 165,000 | 165,000 | | Mitchell Sabshon | 165,000 | 165,000 | | Allison L. Thrush | 150,000 | 150,000 | | Mark Wilsmann | 150,000 | 150,000 |